China National Accord Medicines Corp Ltd
SZSE:000028
China National Accord Medicines Corp Ltd
Pre-Tax Income
China National Accord Medicines Corp Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Pre-Tax Income
¥2.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
Sinopharm Group Co Ltd
HKEX:1099
|
Pre-Tax Income
¥19.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
15%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Pre-Tax Income
¥7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Pre-Tax Income
¥2.9B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
17%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Pre-Tax Income
¥3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
18%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Pre-Tax Income
¥3.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
13%
|
See Also
What is China National Accord Medicines Corp Ltd's Pre-Tax Income?
Pre-Tax Income
2.4B
CNY
Based on the financial report for Mar 31, 2024, China National Accord Medicines Corp Ltd's Pre-Tax Income amounts to 2.4B CNY.
What is China National Accord Medicines Corp Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
13%
Over the last year, the Pre-Tax Income growth was -3%. The average annual Pre-Tax Income growth rates for China National Accord Medicines Corp Ltd have been 3% over the past three years , 7% over the past five years , and 13% over the past ten years .